Clinical Trial Detail

NCT ID NCT01303796
Title A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (SEAMLESS)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Cyclacel Pharmaceuticals, Inc.
Indications

acute myeloid leukemia

Therapies

Decitabine + Sapacitabine

Decitabine

Age Groups: senior

No variant requirements are available.